Cargando…
Point of Care Molecular Testing: Community-Based Rapid Next-Generation Sequencing to Support Cancer Care
Purpose: Biomarker data are critical to the delivery of precision cancer care. The average turnaround of next-generation sequencing (NGS) reports is over 2 weeks, and in-house availability is typically limited to academic centers. Lengthy turnaround times for biomarkers can adversely affect outcomes...
Autores principales: | Sheffield, Brandon S., Beharry, Andrea, Diep, Joanne, Perdrizet, Kirstin, Iafolla, Marco A. J., Raskin, William, Dudani, Shaan, Brett, Mary Anne, Starova, Blerta, Olsen, Brian, Cheema, Parneet K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947443/ https://www.ncbi.nlm.nih.gov/pubmed/35323313 http://dx.doi.org/10.3390/curroncol29030113 |
Ejemplares similares
-
Feasibility of Point-of-Care Genomic Profiling in the Diagnosis and Treatment of Cancer of Unknown Primary
por: Wang, Xin, et al.
Publicado: (2023) -
A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre
por: Cheema, Parneet K., et al.
Publicado: (2022) -
The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer
por: Perdrizet, Kirstin, et al.
Publicado: (2021) -
Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices
por: Sheffield, Brandon S., et al.
Publicado: (2023) -
Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)